Martin Schoen discussing a comparison of outcomes with docetaxel or androgen receptor pathway inhibitor combination therapy for metastatic hormone-sensitive prostate cancer (mHSPC) by volume of ...

PYLARIFY ® (piflufolastat F 18) Injection is a radioactive diagnostic agent indicated or positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with ...

Israeli pharmaceutical company RedHill Biopharma has initiated a placebo-controlled Phase II trial to assess the combination ...

A study found no significant HRQOL differences between Erleada-based therapies and ADT plus AAP for advanced castration-sensitive prostate cancer.

Scottsdale, Arizona - Research Chemical Sciences has introduced a new line of pharmaceutical-grade products, featuring advanced nootropics designed to support cognitive function a ...

Discover the role of phytoestrogens, including soy, in menopause management and breast cancer prevention. Learn how these ...